ema prac naion semaglutide very rare side effect 2025 safety committee to review link between and eye condition ema semaglutide naion label update

Wegovy : Semaglutide sold under the brand name Wegovy is an FDA-approved subcutaneous injection for weight loss in individuals with a body mass index (BMI) of 30 or higher or a BMI of 27 or higher with at least one weight-related health condition

and International Association for the Study of Obesity

You wont magically lose weight or improve your blood sugar markers without changing your diet

(And remember that we dont yet know the BMI requirements for children under 12, since the studies have yet to be concluded

Semaglutide's effects on body composition and metabolism can alter fluid balance, and the accompanying dietary changes may affect overall hydration status